Type
. Validity of the nomenclature of rat leprosy and Mycobacterium lepraemurium. Indian journal of leprosy. 1984;56(3):513-9.
Type
. Cell-mediated immunity in mice treated with Mycobacterium leprae or with macrophages harbouring M. leprae. Annales d'immunologie. 1984;135D(1):39-50.
Type
. Mechanism of immunosuppression in leprosy--macrophage membrane alterations. Journal of clinical & laboratory immunology. 1984;14(3):145-9.
Type
. Pathology of granulomatous diseases. Histiocytic granulomas. International journal of dermatology. 1984;23(6):383-9.
Type
. Leprosy and tuberculosis--an epidemiological comparison. Tubercle. 1984;65(2):137-53.
Type
. Dapsone-resistant leprosy. Leprosy review. 1984;55(2):183.
Type
. C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy. Clinical and experimental immunology [Internet]. 1984;56(3):545-52. Available from: http://ila.ilsl.br/pdfs/v28n2a05.pdf
Type
. Immunochemical characterization of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immunoperoxidase technique (SGIP) using patients' sera. Clinical and experimental immunology. 1984;56(3):537-44.
Type
. Anti-Mycobacterium leprae antibodies in urine from lepromatous patients examined by crossed immunoelectrophoresis and radioimmunoassay. Scandinavian journal of immunology. 1984;19(6):521-8.
Type
. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae. The Journal of infectious diseases. 1984;149(6):870-3.